- Home
- VNDA vs CADL Comparison
VNDA vs CADL Comparison
Compare VNDA & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- CADL
- Stock Information
- Founded
- VNDA 2002
- CADL 1999
- Country
- VNDA United States
- CADL United States
- Employees
- VNDA N/A
- CADL N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- VNDA Health Care
- CADL Health Care
- Exchange
- VNDA Nasdaq
- CADL Nasdaq
- Market Cap
- VNDA 249.4M
- CADL 278.6M
- IPO Year
- VNDA 2006
- CADL 2021
- Fundamental
- Price
- VNDA $4.75
- CADL $5.95
- Analyst Decision
- VNDA Strong Buy
- CADL Strong Buy
- Analyst Count
- VNDA 2
- CADL 5
- Target Price
- VNDA $16.50
- CADL $21.40
- AVG Volume (30 Days)
- VNDA 551.9K
- CADL 651.8K
- Earning Date
- VNDA 07-31-2025
- CADL 08-14-2025
- Dividend Yield
- VNDA N/A
- CADL N/A
- EPS Growth
- VNDA N/A
- CADL N/A
- EPS
- VNDA N/A
- CADL N/A
- Revenue
- VNDA $203,467,000.00
- CADL N/A
- Revenue This Year
- VNDA $16.86
- CADL N/A
- Revenue Next Year
- VNDA $39.78
- CADL N/A
- P/E Ratio
- VNDA N/A
- CADL N/A
- Revenue Growth
- VNDA 11.78
- CADL N/A
- 52 Week Low
- VNDA $3.81
- CADL $3.79
- 52 Week High
- VNDA $5.55
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- VNDA 60.39
- CADL 47.68
- Support Level
- VNDA $4.47
- CADL $5.45
- Resistance Level
- VNDA $4.88
- CADL $6.16
- Average True Range (ATR)
- VNDA 0.16
- CADL 0.32
- MACD
- VNDA 0.05
- CADL -0.07
- Stochastic Oscillator
- VNDA 82.43
- CADL 48.54
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.